Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2020

View Archived Issues

Multistep method wrests causality from GWAS

Loss of neurofibromin enhances ER function and therapy resistance in ER+ breast cancer

Axim Biotechnologies completes preclinical drug studies on SPX-1009

IND application for CS-12192 accepted in China

Intravitreal Eylea approved for neovascular glaucoma

Latuda tablets approved in Japan

Stelara approved for adults with moderate to severe ulcerative colitis in Japan

Phase I data presented for GDC-0214

Novel fungal mouse model of chronic rhinosinusitis

Sanofi receives approval for Soliqua, a combination agent to treat type 2 diabetes, in Japan

Dupixent approved for additional indication of chronic rhinosinusitis with nasal polyp

IL-4 receptor is a therapeutic target in atopic dermatitis

Genentech presents new IRE1 inhibitors

Betta Pharmaceuticals divulges PD-1/PD-L1 and/or PD-L1/CD80 interaction inhibitors

NiKang Therapeutics synthesizes HIF2A inhibitors

Medicenna presents preclinical data on IL-2 Superkine MDNA-19

Velexbru approved in Japan for recurrent or refractory primary central nervous system lymphoma

Japan first in world to approve Viltepso for Duchenne muscular dystrophy

Medshine Discovery identifies new KDM1A inhibitors

Chengdu Kanghong Pharmaceutical patents new analgesics

Japanese approval of Lokelma for hyperkalemia

Scorpion venom could be useful in fetal alcohol spectrum disorders

Phase I data with inzomelid support progression to phase II

Sun Pharma begins healthy volunteer study of SCO-120

LB-1148 improves bowel function after cardiovascular surgery in phase II trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...